| Etanercept in children with polyarticular juvenile rheumatoid arthritis DJ Lovell, EH Giannini, A Reiff, GD Cawkwell, ED Silverman, JJ Nocton, ... New England Journal of Medicine 342 (11), 763-769, 2000 | 1601 | 2000 |
| Preliminary definition of improvement in juvenile arthritis EH Giannini, N Ruperto, A Ravelli, DJ Lovell, DT Felson, A Martini Arthritis & Rheumatism: Official Journal of the American College of …, 1997 | 1369 | 1997 |
| 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the … T Beukelman, NM Patkar, KG Saag, S Tolleson‐Rinehart, RQ Cron, ... Arthritis care & research 63 (4), 465-482, 2011 | 1136 | 2011 |
| Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis F De Benedetti, HI Brunner, N Ruperto, A Kenwright, S Wright, I Calvo, ... New England Journal of Medicine 367 (25), 2385-2395, 2012 | 948 | 2012 |
| De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal‐onset multisystem inflammatory disease (NOMID … I Aksentijevich, M Nowak, M Mallah, JJ Chae, WT Watford, SR Hofmann, ... Arthritis & Rheumatism 46 (12), 3340-3348, 2002 | 844 | 2002 |
| 2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism/American College of … A Ravelli, F Minoia, S Davì, AC Horne, F Bovis, A Pistorio, M Aricò, ... Arthritis & rheumatology 68 (3), 566-576, 2016 | 841 | 2016 |
| Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis N Ruperto, HI Brunner, P Quartier, T Constantin, N Wulffraat, G Horneff, ... New England Journal of Medicine 367 (25), 2396-2406, 2012 | 791 | 2012 |
| Adalimumab with or without methotrexate in juvenile rheumatoid arthritis DJ Lovell, N Ruperto, S Goodman, A Reiff, L Jung, K Jarosova, ... New England Journal of Medicine 359 (8), 810-820, 2008 | 767 | 2008 |
| Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial N Ruperto, DJ Lovell, P Quartier, E Paz, N Rubio-Pérez, CA Silva, ... The Lancet 372 (9636), 383-391, 2008 | 653 | 2008 |
| A randomized, placebo‐controlled trial of infliximab plus methotrexate for the treatment of polyarticular‐course juvenile rheumatoid arthritis N Ruperto, DJ Lovell, R Cuttica, N Wilkinson, P Woo, G Espada, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2007 | 491 | 2007 |
| 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children … S Ringold, PF Weiss, T Beukelman, EM DeWitt, NT Ilowite, Y Kimura, ... Arthritis care & research 65 (10), 1551-1563, 2013 | 486 | 2013 |
| Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis DJ Lovell, A Reiff, NT Ilowite, CA Wallace, Y Chon, SL Lin, ... Arthritis & Rheumatism 58 (5), 1496-1504, 2008 | 449 | 2008 |
| Toward new classification criteria for juvenile idiopathic arthritis: first steps, pediatric rheumatology international trials organization international consensus A Martini, A Ravelli, T Avcin, MW Beresford, R Burgos-Vargas, R Cuttica, ... The Journal of rheumatology 46 (2), 190-197, 2019 | 429 | 2019 |
| 2019 American College of Rheumatology/Arthritis Foundation guideline for the treatment of juvenile idiopathic arthritis: therapeutic approaches for non‐systemic polyarthritis … S Ringold, ST Angeles‐Han, T Beukelman, D Lovell, CA Cuello, ... Arthritis care & research 71 (6), 717-734, 2019 | 424 | 2019 |
| Long‐term efficacy and safety of etanercept in children with polyarticular‐course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open‐label … DJ Lovell, EH Giannini, A Reiff, OY Jones, R Schneider, JC Olson, ... Arthritis & Rheumatism 48 (1), 218-226, 2003 | 368 | 2003 |
| A chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome. A specific entity analysed in 30 patients AM Prieur, C Griscelli, F Lampert, H Truckenbrodt, MA Guggenheim, ... Scandinavian Journal of Rheumatology 16 (sup66), 57-68, 1987 | 360 | 1987 |
| Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis CA Wallace, EH Giannini, SJ Spalding, PJ Hashkes, KM O'Neil, AS Zeft, ... Arthritis & Rheumatism 64 (6), 2012-2021, 2012 | 348 | 2012 |
| Treating juvenile idiopathic arthritis to target: recommendations of an international task force A Ravelli, A Consolaro, G Horneff, RM Laxer, DJ Lovell, NM Wulffraat, ... Annals of the rheumatic diseases 77 (6), 819-828, 2018 | 310 | 2018 |
| Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial HI Brunner, N Ruperto, Z Zuber, C Keane, O Harari, A Kenwright, P Lu, ... Annals of the rheumatic diseases 74 (6), 1110-1117, 2015 | 305 | 2015 |
| 2019 American College of Rheumatology/Arthritis Foundation guideline for the screening, monitoring, and treatment of juvenile idiopathic arthritis–associated uveitis ST Angeles‐Han, S Ringold, T Beukelman, D Lovell, CA Cuello, ... Arthritis & rheumatology 71 (6), 864-877, 2019 | 291 | 2019 |
